The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	24.42B
Revenue (ttm)	15.45B
Net Income (ttm)	3.36B
Shares Out	1.97B
EPS (ttm)	1.85
PE Ratio	6.70
Forward PE	7.66
Dividend	0.62 (4.95%)
Ex-Dividend Date	Sep 25, 2025

Volume	14,207,740
Average Volume	9,423,294
Open	12.50
Previous Close	12.38
Day's Range	12.12 - 12.55
52-Week Range	10.62 - 17.98
Beta	0.12
RSI	39.84
Earnings Date	Nov 28, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY